K12.31 Oral mucositis (ulcerative) due to antineoplastic therapy

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

Additional

code for adverse effect, if applicable, to identify antineoplastic and immunosuppressive drugs (T45.1X5)

GEM Conversion to ICD-9 CM


MDC / MS-DRG Reference


Back Reference of Diagnostic Codes

Mucositis (ulcerative) K12.30
mouth (oral) (oropharyngeal) K12.30

Sibling Codes


Parent Sibling Codes


View in Tabular

Code Title
K00-K95 Diseases of the digestive system (K00-K95)
K00-K14 Diseases of oral cavity and salivary glands (K00-K14)
K12 Stomatitis and related lesions
K12.3 Oral mucositis (ulcerative)
K12.31 Oral mucositis (ulcerative) due to antineoplastic therapy
Use Additional
code for adverse effect, if applicable, to identify antineoplastic and immunosuppressive drugs (T45.1X5)